Madrigal Pharmaceuticals, Inc. MDGL 深 滬
已收盤 11-06 16:00:00 美东时间
399.63
-0.470
-0.12%
華盛通- 最 高401.61
- 今 開400.00
- 成交量 108.86万股
- 最 低 378.275
- 昨 收 400.10
- 總市值 92.33亿
- 52周最高 615.00
- 市盈率 靜 --
- 換手率 4.71%
- 52周最低 353.54
- 委 比 -99.45%
- 總股本 2310.41万
- 歷史最高 615.00
- 量 比 0.92
- 振 幅 5.83%
- 歷史最低 5.25
- 每 手 1
- 風險率 43.52%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Madrigal Pharmaceuticals Inc.收跌0.08%，成交额3.44亿美元
11月6日，Madrigal Pharmaceuticals Inc.（MDGL）收跌0.08%，报400.1美元，成交额3.44亿美元，市值92.94亿美元...
11-06 05:54
Top 3 Health Care Stocks You'll Regret Missing In Q4
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give...
11-05 18:41
美股大行评级 | 大摩上调AMD目标价至725美元；安进、多邻国绩后获华尔街大行看多
今日重点评级关注：康托·菲茨杰拉德：维持Supernus"超配"评级，目标价从67美元升至87美元；丰业银行：维持Atlas Energy Solutions"跑赢大市"评级，目标价从17美元升至18美元
11-05 14:06
美股前瞻 | 民主党横扫国会，美三大期指“V型”反转，道指期货升逾1.8%；马斯克重金助选失利！SpaceX盘前跌逾7%、特斯拉跌逾5%；美国“小非农”高于预期
民主党横扫国会，美三大期指“V型”反转，道指期货升逾1.8%；今晚21:15“小非农”再迎考验；马斯克重金助选失利！SpaceX盘前跌逾7%、特斯拉跌逾5%；今晚21:15“小非农”再迎考验>>
11-04 21:19
美股大行评级 | 苹果、雅诗兰黛、莱迪思半导体均获大行上调目标价
今日重点评级关注：Rosenblatt：维持SiTime"买入"评级，目标价从750美元升至900美元；花旗：维持Madrigal Pharmaceuticals"买入"评级，目标价从725美元升至760美元
11-04 18:17
新浪财经ESG：Madrigal Pharmaceuticals Inc. MSCI（明晟）ESG评级调升至BB
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
11-04 07:01
Citigroup Maintains Buy on Madrigal Pharmaceuticals, Raises Price Target to $760
Citigroup analyst Eric Joseph maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Buy and raises the price target from $725 to $760.
11-04 03:21
财报速睇 | Madrigal Pharmaceuticals, Inc. 2026财年Q3营收4.31亿美元，同比增长50.1%；归母净利润0.55亿美元，扭亏为盈
华盛资讯11月3日讯，Madrigal Pharmaceuticals, Inc.公布2026财年Q3业绩，公司Q3营收4.31亿美元，同比增长50.1%，归母净利润0.55亿美元，扭亏为盈。
11-03 23:03
财报速睇 | Madrigal Pharmaceuticals, Inc. 2026财年Q3营收4.31亿美元，同比增长50.1%；归母净利润0.55亿美元，扭亏为盈
华盛资讯11月3日讯，Madrigal Pharmaceuticals, Inc.公布2026财年Q3业绩，公司Q3营收4.31亿美元，同比增长50.1%，归母净利润0.55亿美元，扭亏为盈。
11-03 22:32
Anavex Life Sciences Names Terrie Kellmeyer, Ph.D., as President and Chief Executive Officer and Member of the Board of Directors
Anavex Life Sciences Corp. appoints Dr. Terrie Kellmeyer as President and CEO, effective November 1, 2026. With over 30 years of experience in biopharmaceuticals, Dr. Kellmeyer has demonstrated strong leadership, advancing Anavex's clinical programs and FDA engagement. She aims to execute clinical plans, generate high-quality data, and maintain transparent communication with stakeholders. Anavex is developing blarcamesine for Alzheimer's, Rett sy...
11-03 12:00
